Immunotherapy represents a sophisticated approach to cancer treatment, leveraging the innate capabilities of the patient's immune system to enhance its anti-tumor response. Research, particularly through clinical trials, has revealed the significant efficacy of anti-PD-1 antibodies. What insights can you provide regarding the underlying mechanisms contributing to the effectiveness of such a therapeutic strategy?